In N-ERD, overexpression of PGD2 may explain the increase in VEGF, and suppression of VEGF production could be a potential mechanism, by which nasal polyp recurrence is reduced in N-ERD. The gene discussed is VEGFA; the disease is nasal cavity polyp.